Characterization of matrix metalloproteinase-2 and -9 in cerebrospinal fluid of clinically normal dogs
Authors:
- Karen D. InzanaKIKaren D. Inzana
- Thomas J. InzanaTIThomas J. Inzana
- 1 October 2002
- journal article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 63 (10) , 1359-1362
Abstract
Objective —To characterize matrix metalloproteinase (MMP)-2 and -9 in CSF of clinically normal dogs. Sample Population —Samples of CSF collected from 23 dogs. Procedure —Dogs were anesthetized, CSF samples were collected, and dogs were then euthanatized. Each CSF sample was evaluated immediately for RBC count, WBC count, and protein and glucose concentrations, and cytologic examination also was performed. Samples were considered normal when protein concentration was < 25 mg/dL and CSF contained < 6 WBCs/μL and < 25 RBCs/μL. Samples were stored at –70°C. Sections of brain tissue were collected and processed for histologic examination. The MMPs were evaluated by use of gelatin zymography and a polyclonal antibody-based sandwich ELISA. Results —Mean WBC count for CSF samples was < 1 WBC/μL (range, 0 to 3 WBCs/mL). Mean protein concentration was 12 mg/dL (range, 8 to 17 mg/dL). Mean RBC count was 3.65 RBCs/μL (range, 0 to 21 RBCs/μL). All CSF samples generated a clear band on zymography gels that corresponded to the human commercial standard of proenzyme MMP-2. Other major clear bands were not detected on zymography gels. Bands correlating to MMP-9 were not detected in any samples. The ELISA results revealed a mean ± SD proenzyme MMP-2 concentration of 5.61 ± 1.92 ng/mL (range, 3.36 to 10.83 ng/mL). Conclusions and Clinical Relevance —The proenzyme form of MMP-2 is detectable in CSF of clinically normal dogs, whereas MMP-9 is not detectable. Additional investigation of MMPs in CSF from dogs with various diseases of the nervous system is indicated. ( Am J Vet Res 2002;63:1359–1362)Keywords
This publication has 23 references indexed in Scilit:
- Identification of Matrix Metalloproteinases in Canine Cutaneous Mast Cell TumorsJournal of Veterinary Internal Medicine, 2000
- Matrix Metalloproteinases in Cerebrovascular DiseaseJournal of Cerebral Blood Flow & Metabolism, 1998
- Isolation and identification of canine matrixmetalloproteinase-2 (MMP-2)The Veterinary Journal, 1998
- Matrix Metalloproteinases in the Neocortex and Spinal Cord of Amyotrophic Lateral Sclerosis PatientsJournal of Neurochemistry, 1996
- Effect of steroids on CSF matrix metalloproteinases in multiple sclerosisNeurology, 1996
- Diagnosis of Inflammatory and Infectious Diseases of the Central Nervous System in Dogs: A Retrospective StudyJournal of Veterinary Internal Medicine, 1995
- Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomasJournal of Neurosurgery, 1995
- Electrophoretic analysis of proteins associated with tumor cell invasionElectrophoresis, 1994
- Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disordersJournal of Neuroimmunology, 1992
- Further purification and some properties of a gelatin-specific proteinase of human leucocytesBiochimica et Biophysica Acta (BBA) - General Subjects, 1982